Primary record
1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- 库存
- 3,062 克
- 纯度
- 99.1 %
- CAS
- 144690-92-6
化合物标识与属性
- CAS
- 144690-92-6
- PubChem CID
- 19036162
- SMILES
- CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=NN4C(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)C(=O)OCC8=C(OC(=O)O8)C)C(C)(C)O
- Canonical SMILES
- CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(-c2ccccc2-c2nnnn2C(c2ccccc2)(c2ccccc2)c2ccccc2)cc1
名称与同义词
- Trityl Olmesartan Medoxomil
- Trityl olmesartan
- Tritylolmesartan medoxomil
- 144690-92-6
- Triphenyl methyl olmesartan
- N1-Tritylolmesartan medoxomil
- Olmesartan Impurity 12
- RefChem:192216
- Trityl Olmesartan edoxomil
- UNII-8591TIT360
- N-1 Trityl Olmesartan Medoxomil
- MFCD09954745
- DTXSID70162785
- C48H44N6O6
- orb1909121
- SCHEMBL1653541
- 1H-Imidazole-5-carboxylic acid
- 8591TIT360
- DTXCID2085276
- CTK8E7600
- IJOPLMOXIPGJIJ-UHFFFAOYSA-N
- KS-00000H8B
- ZINC94313257
- Olmesartan Medoxomil N-alkyl impurity
- AKOS015896144
- AC-3500
- ACN-039797
- AM90291
- IH57932
- RP17801
- SB41036
- EC 604-437-3
- QUINACRINEDIHYDROCHLORIDEDIHYDRATE
- AN-12900
- AS-12483
- SY110528
- AB0012009
- DB-063556
- RT-016145
- TL8006165
- CS-0138129
- FT-0657780
- NS00008283
- J2.567.715C
- F19426
- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate
- A808264
- Olmesartan medoxomil impurity, N-alkyl impurity- [USP]
- I06-1660
- Olmesartan medoxomil impurity, N-alkyl impurity-(USP)
- Olmesartan medoxomil impurity, N-alkyl impurity-[USP]
- Q27269619
- (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylate
- 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- B0176-058864
- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
- (5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-({2'-[1-(triphenylmethyl)-1H-1,2,3,4-tetrazol-5-yl]-[1,1'-biphenyl]-4-yl}methyl)-1H-imidazole-5-carboxylate
- Olmesartan USP Impurity D; Olmesartan Medoxomil Impurity G
- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate
- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(1-hydroxy-1-methyl-ethyl)-2-propyl-3-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
- 1h-imidazole-5-carboxylic acid,4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1h-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-,(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester
- 5-(1-Hydroxy-1-methyl-ethyl)-2-propyl-3-[2'-(1-trityl-1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-imidazole-4-carboxylic acid 5-methyl-2-oxo-[1,3]dioxol-4-ylmethyl ester
- OLMESARTAN MEDOXOMIL IMPURITY, N-ALKYL IMPURITY- [USP IMPURITY]
- OLMESARTAN MEDOXOMIL IMPURITY, N-ALKYL IMPURITY-(USP IMPURITY)
- OLMESARTAN MEDOXOMIL IMPURITY, N-ALKYL IMPURITY-[USP IMPURITY]
- (5-methyl -2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(trityltetrazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylate
- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate
- (5-Methyl-2-oxo-1,3-dioxole-4-yl)methyl=4-(2-hydroxypropane-2-yl)-2-propyl-1-[[2 -(1-trityl-1H-tetrazole-5-yl)biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylate
- (5-Methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(trityltetrazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylate
- (5-Methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-{trityltetrazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylate
- (5-Methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-({2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl}methyl)-1H-imidazole-5-carboxylate
- 1-[2 -(1-Trityl-1H-tetrazole-5-yl)-4-biphenylylmethyl]-2-propyl-4-(1-hydroxy-1-methylethyl)-1H-imidazole-5-carboxylic acid 2-oxo-5-methyl-1,3-dioxole-4-ylmethyl ester
- 1h-imidazole-5-carboxylic acid,4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1-(triphenylmethyl)-1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl)methyl)-,(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]m ethyl]-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1[4-[2-(trityltetrazol-5-yl)phenyl]phenyl]methylimidazo-5-carboxylate (5-methyl-2-oxo-1,3-dioxo len-4-yl)methyl
- 4-(2-Hydroxypropane-2-yl)-2-propyl-1-[[2 -(1-trityl-1H-tetrazole-5-yl)biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxole-4-yl)methyl ester
- 604-437-3